IL152956A0 - Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents - Google Patents
Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agentsInfo
- Publication number
- IL152956A0 IL152956A0 IL15295601A IL15295601A IL152956A0 IL 152956 A0 IL152956 A0 IL 152956A0 IL 15295601 A IL15295601 A IL 15295601A IL 15295601 A IL15295601 A IL 15295601A IL 152956 A0 IL152956 A0 IL 152956A0
- Authority
- IL
- Israel
- Prior art keywords
- alkylating agents
- combined therapy
- against tumors
- therapy against
- distamycin derivatives
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- -1 acryloyl distamycin derivatives Chemical class 0.000 title 1
- 239000002168 alkylating agent Chemical class 0.000 title 1
- 229940100198 alkylating agent Drugs 0.000 title 1
- 238000002648 combination therapy Methods 0.000 title 1
- UPBAOYRENQEPJO-UHFFFAOYSA-N n-[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-4-formamido-1-methylpyrrole-2-carboxamide Chemical class CN1C=C(NC=O)C=C1C(=O)NC1=CN(C)C(C(=O)NC2=CN(C)C(C(=O)NCCC(N)=N)=C2)=C1 UPBAOYRENQEPJO-UHFFFAOYSA-N 0.000 abstract 2
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 229910052801 chlorine Chemical group 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000002254 cytotoxic agent Substances 0.000 abstract 1
- 231100000599 cytotoxic agent Toxicity 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 108010042747 stallimycin Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0015447.6A GB0015447D0 (en) | 2000-06-23 | 2000-06-23 | Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents |
| PCT/EP2001/007064 WO2001097790A2 (en) | 2000-06-23 | 2001-06-20 | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL152956A0 true IL152956A0 (en) | 2003-06-24 |
Family
ID=9894288
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15295601A IL152956A0 (en) | 2000-06-23 | 2001-06-20 | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| IL152956A IL152956A (en) | 2000-06-23 | 2002-11-20 | Combined Pharmaceutical Preparations Containing Transformed History Of Acryloyl Dystamycin And Alkylation Materials And Uses |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL152956A IL152956A (en) | 2000-06-23 | 2002-11-20 | Combined Pharmaceutical Preparations Containing Transformed History Of Acryloyl Dystamycin And Alkylation Materials And Uses |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8642580B2 (enExample) |
| EP (1) | EP1303307B1 (enExample) |
| JP (1) | JP2003535891A (enExample) |
| KR (1) | KR100869037B1 (enExample) |
| CN (1) | CN100479860C (enExample) |
| AT (1) | ATE362365T1 (enExample) |
| AU (2) | AU8186701A (enExample) |
| BR (1) | BR0111740A (enExample) |
| CA (1) | CA2410160C (enExample) |
| CY (1) | CY1106713T1 (enExample) |
| CZ (1) | CZ301053B6 (enExample) |
| DE (1) | DE60128472T2 (enExample) |
| DK (1) | DK1303307T3 (enExample) |
| EA (1) | EA008502B1 (enExample) |
| EE (1) | EE05300B1 (enExample) |
| ES (1) | ES2284674T3 (enExample) |
| GB (1) | GB0015447D0 (enExample) |
| HK (1) | HK1054335B (enExample) |
| HU (1) | HUP0301234A2 (enExample) |
| IL (2) | IL152956A0 (enExample) |
| MX (1) | MXPA02012209A (enExample) |
| NO (1) | NO329782B1 (enExample) |
| NZ (1) | NZ522999A (enExample) |
| PL (1) | PL202053B1 (enExample) |
| PT (1) | PT1303307E (enExample) |
| SK (1) | SK18342002A3 (enExample) |
| WO (1) | WO2001097790A2 (enExample) |
| ZA (1) | ZA200209836B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL371179A1 (en) * | 2002-01-02 | 2005-06-13 | Pharmacia Italia S.P.A. | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| IL164356A0 (en) * | 2002-04-02 | 2005-12-18 | Pharmacia Italia Spa | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| MD35Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare |
| MD36Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare |
| MD24Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare |
| MD23Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare |
| US9527863B2 (en) * | 2012-04-05 | 2016-12-27 | Nerviano Medical Sciences S.R.L. | Thieno-indole moieties and methods of treating using the same |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56154493A (en) * | 1980-04-30 | 1981-11-30 | Shionogi & Co Ltd | Novel platinum complex |
| CN85103908A (zh) * | 1985-07-16 | 1986-11-05 | 法米塔利·卡洛·埃尔巴有限公司 | 制备4′-表多克索红菌素的新方法 |
| AT387013B (de) | 1985-07-16 | 1988-11-25 | Erba Farmitalia | Verfahren zur herstellung von poly-4-aminopyrrol -2-carboxamidoderivaten |
| GB8612218D0 (en) | 1986-05-20 | 1986-06-25 | Erba Farmitalia | Site specific alkylating agents |
| KR950013762B1 (en) | 1986-10-07 | 1995-11-15 | Boehringer Mannheim Italia | Pharmaceutical compositions having antineoplastic activity |
| GB8906709D0 (en) | 1989-03-23 | 1989-05-10 | Creighton Andrew M | Acryloyl substituted pyrrole derivatives |
| JP2919867B2 (ja) | 1989-09-27 | 1999-07-19 | 千寿製薬株式会社 | 抗腫瘍剤 |
| GB9000644D0 (en) * | 1990-01-11 | 1990-03-14 | Erba Carlo Spa | New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| IT1272234B (it) | 1994-05-02 | 1997-06-16 | Consiglio Nazionale Ricerche | Derivati glutationici delle antracicline e procedimento per ottenerli. |
| GB9416005D0 (en) | 1994-08-08 | 1994-09-28 | Erba Carlo Spa | Peptidic compounds analogous to distamycin a and process for their preparation |
| US5880097A (en) | 1996-01-04 | 1999-03-09 | Terrapin Techologies, Inc. | Tethered prodrugs |
| WO1997028123A1 (en) | 1996-02-02 | 1997-08-07 | Pharmacia & Upjohn S.P.A. | Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| GB9610079D0 (en) | 1996-05-14 | 1996-07-17 | Pharmacia Spa | Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents |
| GB9615692D0 (en) * | 1996-07-25 | 1996-09-04 | Pharmacia Spa | Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| GB9623522D0 (en) | 1996-11-11 | 1997-01-08 | Pharmacia & Upjohn Spa | Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents |
| GB9727524D0 (en) * | 1997-12-31 | 1998-02-25 | Pharmacia & Upjohn Spa | Synergistic antitumor composition containing a biologically active ureido compound |
| GB9806689D0 (en) | 1998-03-27 | 1998-05-27 | Pharmacia & Upjohn Spa | Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents |
| GB9806692D0 (en) * | 1998-03-27 | 1998-05-27 | Pharmacia & Upjohn Spa | Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents |
| GB9816653D0 (en) | 1998-07-30 | 1998-09-30 | Pharmacia & Upjohn Spa | Oxidised sulfurated distamycin derivatives process for preparing them and their use as antitumor agents |
| GB9816652D0 (en) | 1998-07-30 | 1998-09-30 | Pharmacia & Upjohn Spa | Sulfurated distamycin derivatives process for preparing them and their use as antitumor agents |
| GB9928703D0 (en) | 1999-12-03 | 2000-02-02 | Pharmacia & Upjohn Spa | Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents |
| GB0011059D0 (en) * | 2000-05-08 | 2000-06-28 | Pharmacia & Upjohn Spa | Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione |
| GB0015444D0 (en) * | 2000-06-23 | 2000-08-16 | Pharmacia & Upjohn Spa | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors |
| US6576612B1 (en) * | 2000-10-02 | 2003-06-10 | Pharmacia Italia S.P.A. | Antitumor therapy comprising distamycin derivatives |
-
2000
- 2000-06-23 GB GBGB0015447.6A patent/GB0015447D0/en not_active Ceased
-
2001
- 2001-06-20 CN CNB018114776A patent/CN100479860C/zh not_active Expired - Fee Related
- 2001-06-20 HK HK03106772.8A patent/HK1054335B/zh not_active IP Right Cessation
- 2001-06-20 JP JP2002503267A patent/JP2003535891A/ja not_active Withdrawn
- 2001-06-20 US US10/311,995 patent/US8642580B2/en not_active Expired - Fee Related
- 2001-06-20 KR KR1020027017565A patent/KR100869037B1/ko not_active Expired - Fee Related
- 2001-06-20 AU AU8186701A patent/AU8186701A/xx active Pending
- 2001-06-20 WO PCT/EP2001/007064 patent/WO2001097790A2/en not_active Ceased
- 2001-06-20 CZ CZ20024106A patent/CZ301053B6/cs not_active IP Right Cessation
- 2001-06-20 EP EP01960355A patent/EP1303307B1/en not_active Expired - Lifetime
- 2001-06-20 AT AT01960355T patent/ATE362365T1/de not_active IP Right Cessation
- 2001-06-20 DK DK01960355T patent/DK1303307T3/da active
- 2001-06-20 EA EA200300061A patent/EA008502B1/ru not_active IP Right Cessation
- 2001-06-20 MX MXPA02012209A patent/MXPA02012209A/es active IP Right Grant
- 2001-06-20 PL PL365158A patent/PL202053B1/pl not_active IP Right Cessation
- 2001-06-20 EE EEP200200660A patent/EE05300B1/xx not_active IP Right Cessation
- 2001-06-20 SK SK1834-2002A patent/SK18342002A3/sk unknown
- 2001-06-20 CA CA002410160A patent/CA2410160C/en not_active Expired - Fee Related
- 2001-06-20 DE DE60128472T patent/DE60128472T2/de not_active Expired - Lifetime
- 2001-06-20 NZ NZ522999A patent/NZ522999A/en unknown
- 2001-06-20 IL IL15295601A patent/IL152956A0/xx unknown
- 2001-06-20 AU AU2001281867A patent/AU2001281867B2/en not_active Ceased
- 2001-06-20 HU HU0301234A patent/HUP0301234A2/hu unknown
- 2001-06-20 PT PT01960355T patent/PT1303307E/pt unknown
- 2001-06-20 BR BR0111740-8A patent/BR0111740A/pt not_active Application Discontinuation
- 2001-06-20 ES ES01960355T patent/ES2284674T3/es not_active Expired - Lifetime
-
2002
- 2002-11-20 IL IL152956A patent/IL152956A/en not_active IP Right Cessation
- 2002-12-04 ZA ZA200209836A patent/ZA200209836B/en unknown
- 2002-12-18 NO NO20026077A patent/NO329782B1/no not_active IP Right Cessation
-
2007
- 2007-07-09 CY CY20071100908T patent/CY1106713T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY138352A (en) | Benzothiazole derivatives | |
| MX2007003321A (es) | Derivados heterociclicos y su uso como agentes terapeuticos. | |
| GB0005251D0 (en) | Therapeutic compounds | |
| TNSN06032A1 (en) | Pyridazine derivatives and their use as therapeutic agents | |
| TW200626572A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
| TNSN06034A1 (en) | Pyridazine derivatives and their use as therapeutic agents | |
| TW200626592A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
| TW200626139A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
| GB0025173D0 (en) | Therapeutic agents | |
| TW200626154A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
| TW200638935A (en) | Pyridazine derivatives and their use as therapeutic agents | |
| PL373414A1 (en) | 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands | |
| MXPA05003104A (es) | Hidromorfonas n-sustituidas y uso de las mismas. | |
| BRPI0409959A (pt) | uso de derivados de azetidinacarboxamida em terapia | |
| IL184116A0 (en) | Use of thiazolidinone derivatives as antiangiogenic agents | |
| IL152956A0 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents | |
| DK1206444T3 (da) | Forbindelser der hæmmer tryptaseaktivitet | |
| GB0011059D0 (en) | Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione | |
| IL160082A0 (en) | Quinoline derivatives and use thereof as antitumor agents | |
| MXPA03003971A (es) | Derivados de indol como inhibidores de pde5. | |
| PL371741A1 (en) | A combination treatment for acute myocardial infarction | |
| GB0522908D0 (en) | Therapeutic agents | |
| MY144229A (en) | Pyridazine derivatives and their use as therapeutic agents | |
| DE60022047D1 (de) | Antivirale therapie | |
| ATE270886T1 (de) | Antivirale therapie |